Tobias Piegeler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tobias Piegeler has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Sebastian Stehr
Universitätsklinikum Leipzig AöR
5 shared publications - Gunther Hempel
Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Leipzig AöR, Leipzig, Deutschland
3 shared publications - Achim Schmitz
Department of Anaesthesia, University Children's Hospital, Zurich, Switzerland
2 shared publications Jae-Hwi Jang
Univ Hosp Zurich, Dept Thorac Surg, Zurich, Switzerland
2 shared publications- Jörg Thomas
University Children's Hospital, Steinwiesstr. 75, CH-8032 Zürich, Switzerland
2 shared publications - Markus Weiss
Department of Anesthesia University Children's Hospital Zurich Switzerland
2 shared publications
Latest Publications
- 20 July 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Making the Surgical Safety Checklist Even Safer: A Team Timeout Checklist to Improve Information Exchange and Interprofessional Communication Before Skin Incision
BACKGROUND: The World Health Organization surgical safety checklist (WHO SSC) provides a standardized framework for preoperative safety procedures. However, studies have revealed substantial variation in adherence, with items being skipped or misunderstood and nurses likely to be less involved than other operating room (OR) professional groups. We introduce a 16-item team timeout checklist (TTOC) that clarifies and adds safety-critical items to the existing WHO before skin incision timeout and is led by nurses to improve information exchange, closed-loop communication, and encouraging participation of all professional groups. METHODS: Using a prospective pre–post interventional design, we live-coded all team communication during on-site observations in the OR focusing on the pre-incision phase. Surgical teams were first observed during a pre-intervention period without the TTOC checklist and subsequently during a post-intervention period after implementation of the TTOC checklist. The TTOC was evaluated on four communication outcomes critical for patient safety: information exchange of checklist items, measured as the percentage of the 16 items that were verbally communicated among team members (eg, team introduction, surgical site, allergies), participation rates of different professional groups, frequency of explicit coordination behaviors (eg, instruction, information request, speaking up) and the frequency of closed-loop communication sequences, defined as information request followed by information upon request within 30 seconds. RESULTS: A total of 155 teams were observed, including 78 teams in the pre-intervention phase without TTOC use and 77 teams in the post-intervention phase using the TTOC, resulting in 13,127 coded communication events. The median information exchange increased from 62.5% (interquartile range [IQR] 50–68.8) in the pre-intervention phase to 100% (IQR 100–100) in the post-intervention phase ( P < .001). For 15 of all 16 subitems, the odds of exchanging information were significantly higher after TTOC implementation than before TTOC implementation (odds ratios range 10.8–1896, all 95% confidence intervals [CIs] excluded 1). Participation rates increased for circulating nurses, scrub nurses, surgical residents, and anesthesia (all P < .05) but not for lead surgeons. Mean (standard deviation [SD]) closed-loop communication patterns per operation were more frequent with (20.4 [10.7]) than without the TTOC (16.4, [7.24]), P = .004. CONCLUSIONS: In our study, the nurse-led TTOC significantly improved the exchange of safety-critical items during the pre-incision phase, facilitated closed-loop communication, and empowered the participation of various professional groups. These findings suggest integrating the TTOC with the WHO SSC before-incision protocol may have important advantages.
- 20 July 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
Making the Surgical Safety Checklist Even Safer: A Team Timeout Checklist to Improve Information Exchange and Interprofessional Communication Before Skin Incision
BACKGROUND: The World Health Organization surgical safety checklist (WHO SSC) provides a standardized framework for preoperative safety procedures. However, studies have revealed substantial variation in adherence, with items being skipped or misunderstood and nurses likely to be less involved than other operating room (OR) professional groups. We introduce a 16-item team timeout checklist (TTOC) that clarifies and adds safety-critical items to the existing WHO before skin incision timeout and is led by nurses to improve information exchange, closed-loop communication, and encouraging participation of all professional groups. METHODS: Using a prospective pre–post interventional design, we live-coded all team communication during on-site observations in the OR focusing on the pre-incision phase. Surgical teams were first observed during a pre-intervention period without the TTOC checklist and subsequently during a post-intervention period after implementation of the TTOC checklist. The TTOC was evaluated on four communication outcomes critical for patient safety: information exchange of checklist items, measured as the percentage of the 16 items that were verbally communicated among team members (eg, team introduction, surgical site, allergies), participation rates of different professional groups, frequency of explicit coordination behaviors (eg, instruction, information request, speaking up) and the frequency of closed-loop communication sequences, defined as information request followed by information upon request within 30 seconds. RESULTS: A total of 155 teams were observed, including 78 teams in the pre-intervention phase without TTOC use and 77 teams in the post-intervention phase using the TTOC, resulting in 13,127 coded communication events. The median information exchange increased from 62.5% (interquartile range [IQR] 50–68.8) in the pre-intervention phase to 100% (IQR 100–100) in the post-intervention phase ( P < .001). For 15 of all 16 subitems, the odds of exchanging information were significantly higher after TTOC implementation than before TTOC implementation (odds ratios range 10.8–1896, all 95% confidence intervals [CIs] excluded 1). Participation rates increased for circulating nurses, scrub nurses, surgical residents, and anesthesia (all P < .05) but not for lead surgeons. Mean (standard deviation [SD]) closed-loop communication patterns per operation were more frequent with (20.4 [10.7]) than without the TTOC (16.4, [7.24]), P = .004. CONCLUSIONS: In our study, the nurse-led TTOC significantly improved the exchange of safety-critical items during the pre-incision phase, facilitated closed-loop communication, and empowered the participation of various professional groups. These findings suggest integrating the TTOC with the WHO SSC before-incision protocol may have important advantages.
- Open Access
- 28 January 2026
- Published by Springer Nature in Die Anaesthesiologie
- Vol. 75 (3) , 175-184
Perioperatives anästhesiologisches Management der postmortalen Organspende in Deutschland – Eine prospektive Querschnittstudie mittels Online-Fragebogen
Zusammenfassung: Hintergrund: Im Gegensatz zur intensivmedizinischen Therapie existieren bisher keine Handlungsempfehlungen zum anästhesiologischen Management postmortaler Organspenderinnen und Organspender in Deutschland. Zudem ist unbekannt, wie die anästhesiologische Versorgung in den Entnahme-Krankenhäusern durchgeführt wird. Ziel der Arbeit: Erfassung der Praxis des anästhesiologischen Managements der postmortalen Organspende. Methoden: Prospektive Querschnittstudie (DRKS00033627) mittels anonymisierter Online-Umfrage unter den Mitgliedern der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin sowie den bei der Deutschen Stiftung für Organtransplantation registrierten Transplantationsbeauftragten. Neben demografischen Angaben und der eigenen Erfahrung in der Betreuung von Organspenderinnen und Organspendern wurde das konkrete anästhesiologische Vorgehen während eines solchen Eingriffs erfragt. Ergebnisse: Es wurden insgesamt 951 Fragebogen aus allen stationären Versorgungsstufen ausgewertet (28 % Grund‑/Regelversorger, 29 % Schwerpunktversorger, 17 % Maximalversorger, 24 % Universitätskliniken, 1 % Sonstige). Die Antworten zum konkreten Vorgehen, insbesondere bezüglich der eingesetzten Medikamente und der Indikation zur Transfusion von Erythrozytenkonzentraten, waren insgesamt heterogen. In einer multivariaten logistische Regressionsanalyse zeigte sich, dass neben der Versorgungsstufe der Kliniken v. a. die Absolvierung des Curriculums „Transplantationsbeauftragter Arzt“ einen Einfluss auf die Verabreichung spezifischer (potenziell organprotektiver) Medikamente haben könnte. Diskussion: Die anästhesiologische Betreuung zur postmortalen Organspende wird in Deutschland aktuell sehr unterschiedlich gehandhabt. Die Erstellung von Handlungsempfehlungen erscheint daher angezeigt.
- 28 January 2026
- Published by Springer Nature in Die Anaesthesiologie
- Vol. 75 (3) , 175-184
Open AccessPerioperatives anästhesiologisches Management der postmortalen Organspende in Deutschland – Eine prospektive Querschnittstudie mittels Online-Fragebogen
Zusammenfassung: Hintergrund: Im Gegensatz zur intensivmedizinischen Therapie existieren bisher keine Handlungsempfehlungen zum anästhesiologischen Management postmortaler Organspenderinnen und Organspender in Deutschland. Zudem ist unbekannt, wie die anästhesiologische Versorgung in den Entnahme-Krankenhäusern durchgeführt wird. Ziel der Arbeit: Erfassung der Praxis des anästhesiologischen Managements der postmortalen Organspende. Methoden: Prospektive Querschnittstudie (DRKS00033627) mittels anonymisierter Online-Umfrage unter den Mitgliedern der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin sowie den bei der Deutschen Stiftung für Organtransplantation registrierten Transplantationsbeauftragten. Neben demografischen Angaben und der eigenen Erfahrung in der Betreuung von Organspenderinnen und Organspendern wurde das konkrete anästhesiologische Vorgehen während eines solchen Eingriffs erfragt. Ergebnisse: Es wurden insgesamt 951 Fragebogen aus allen stationären Versorgungsstufen ausgewertet (28 % Grund‑/Regelversorger, 29 % Schwerpunktversorger, 17 % Maximalversorger, 24 % Universitätskliniken, 1 % Sonstige). Die Antworten zum konkreten Vorgehen, insbesondere bezüglich der eingesetzten Medikamente und der Indikation zur Transfusion von Erythrozytenkonzentraten, waren insgesamt heterogen. In einer multivariaten logistische Regressionsanalyse zeigte sich, dass neben der Versorgungsstufe der Kliniken v. a. die Absolvierung des Curriculums „Transplantationsbeauftragter Arzt“ einen Einfluss auf die Verabreichung spezifischer (potenziell organprotektiver) Medikamente haben könnte. Diskussion: Die anästhesiologische Betreuung zur postmortalen Organspende wird in Deutschland aktuell sehr unterschiedlich gehandhabt. Die Erstellung von Handlungsempfehlungen erscheint daher angezeigt.
- Open Access
- 30 September 2025
- Published by Wiley in Advanced Biology
- Vol. 9 (12) , e00280
Amide‐Linked Local Anesthetics Alter Tumor Biology in a Complex Human Tissue Model of Non‐Small Cell Lung Adenocarcinoma
Amide local anesthetics (LA) affect tumor burden in various preclinical studies, possibly via their anti‐inflammatory properties. However, a translation into clinical evidence is still lacking. Here, effects of LA at clinically relevant concentrations are assessed using a human ex vivo tumor model of patient‐derived tumor slice cultures from nine patients with non‐small cell lung cancer. Tumors are cultivated for four days and treated with LA in absence/presence of cisplatin. Tumor cell proliferation and apoptosis as well as expression of intercellular adhesion molecule‐1 and macrophage polarization are assessed using immunofluorescent imaging. Tumor specimens are considered to be “Responders”, when a change in proliferation and/or apoptosis by >50% compared to untreated slices occurred. Five of nine samples are “Responders”, in which the LA exerted effects comparable to cisplatin. Even at clinically relevant concentrations of LA, a strong anti‐tumoral effect is observable in patient‐derived tumor slice cultures with complex structures of the tumor microenvironment highlighting the LA effect on the tumor itself and its surroundings, without any interference by other leukocytes or neuronal stimulation. The diverse reaction to LA treatment also emphasizes the importance of biomarkers to determine the tumor phenotypes, which may benefit from LA treatment.
- 30 September 2025
- Published by Wiley in Advanced Biology
- Vol. 9 (12) , e00280
Open AccessAmide‐Linked Local Anesthetics Alter Tumor Biology in a Complex Human Tissue Model of Non‐Small Cell Lung Adenocarcinoma
Amide local anesthetics (LA) affect tumor burden in various preclinical studies, possibly via their anti‐inflammatory properties. However, a translation into clinical evidence is still lacking. Here, effects of LA at clinically relevant concentrations are assessed using a human ex vivo tumor model of patient‐derived tumor slice cultures from nine patients with non‐small cell lung cancer. Tumors are cultivated for four days and treated with LA in absence/presence of cisplatin. Tumor cell proliferation and apoptosis as well as expression of intercellular adhesion molecule‐1 and macrophage polarization are assessed using immunofluorescent imaging. Tumor specimens are considered to be “Responders”, when a change in proliferation and/or apoptosis by >50% compared to untreated slices occurred. Five of nine samples are “Responders”, in which the LA exerted effects comparable to cisplatin. Even at clinically relevant concentrations of LA, a strong anti‐tumoral effect is observable in patient‐derived tumor slice cultures with complex structures of the tumor microenvironment highlighting the LA effect on the tumor itself and its surroundings, without any interference by other leukocytes or neuronal stimulation. The diverse reaction to LA treatment also emphasizes the importance of biomarkers to determine the tumor phenotypes, which may benefit from LA treatment.
- Open Access
- 1 September 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-8
Superior recovery and efficiency with laryngeal mask airway compared to endotracheal intubation in minimally invasive repair of pectus excavatum: a retrospective analysis
Background: Minimally invasive repair is the standard treatment for patients with pectus excavatum. Recent data suggest that using a laryngeal mask airway during thoracic surgery might offer advantages over endotracheal intubation, such as faster recovery from surgery, shorter anesthesia times and fewer complications. The aim of this study was to evaluate the safety and potential benefits of laryngeal mask airway use in minimally invasive pectus excavatum repair. Methods: Retrospective analysis of electronic anesthesia protocols and records of patients who underwent pectus excavatum repair at a large academic center between 2019 and 2024. Perioperative data, complications, and procedural times were evaluated. Patients who had their airways secured with endotracheal intubation were compared to those who were ventilated using a laryngeal mask. Results: Data of 48 patients were analyzed (n = 32 with endotracheal intubation, n = 16 for laryngeal mask). The use of a laryngeal mask significantly shortened anesthesia induction time (4.0 vs. 7.5 min, p = 0.002), recovery time (9.1 vs. 19.0 min, p = 0.002) and emergence time (7.0 vs. 17.0 min, p < 0.001). Patients in the laryngeal mask group also had a significantly reduced need for postoperative oxygen supplementation (6.3 vs. 36.8%, p = 0.008). There were fewer anesthesiologic complications when a laryngeal mask was used, although this difference did not reach statistical significance (6.3 vs. 18.5%, p = 0.65). Hospital (6 vs. 5.5 days, p = 0.81) and ICU length of stay (21.73 vs. 23.84 h, p = 0.31), surgical complications (18.8 vs. 15.6%, p = 0.79) and incision-suture time (90.3 vs. 89.7 min, p = 0.92) were comparable in both groups. Conclusions: The use of a laryngeal mask in minimally invasive pectus excavatum repair is safe and effective. Its advantages— reduced respiratory complications and shorter anesthesia-related times—support its use as an alternative airway device for this procedure for medical as well as for economic reasons.
- 1 September 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-8
Open AccessSuperior recovery and efficiency with laryngeal mask airway compared to endotracheal intubation in minimally invasive repair of pectus excavatum: a retrospective analysis
Background: Minimally invasive repair is the standard treatment for patients with pectus excavatum. Recent data suggest that using a laryngeal mask airway during thoracic surgery might offer advantages over endotracheal intubation, such as faster recovery from surgery, shorter anesthesia times and fewer complications. The aim of this study was to evaluate the safety and potential benefits of laryngeal mask airway use in minimally invasive pectus excavatum repair. Methods: Retrospective analysis of electronic anesthesia protocols and records of patients who underwent pectus excavatum repair at a large academic center between 2019 and 2024. Perioperative data, complications, and procedural times were evaluated. Patients who had their airways secured with endotracheal intubation were compared to those who were ventilated using a laryngeal mask. Results: Data of 48 patients were analyzed (n = 32 with endotracheal intubation, n = 16 for laryngeal mask). The use of a laryngeal mask significantly shortened anesthesia induction time (4.0 vs. 7.5 min, p = 0.002), recovery time (9.1 vs. 19.0 min, p = 0.002) and emergence time (7.0 vs. 17.0 min, p < 0.001). Patients in the laryngeal mask group also had a significantly reduced need for postoperative oxygen supplementation (6.3 vs. 36.8%, p = 0.008). There were fewer anesthesiologic complications when a laryngeal mask was used, although this difference did not reach statistical significance (6.3 vs. 18.5%, p = 0.65). Hospital (6 vs. 5.5 days, p = 0.81) and ICU length of stay (21.73 vs. 23.84 h, p = 0.31), surgical complications (18.8 vs. 15.6%, p = 0.79) and incision-suture time (90.3 vs. 89.7 min, p = 0.92) were comparable in both groups. Conclusions: The use of a laryngeal mask in minimally invasive pectus excavatum repair is safe and effective. Its advantages— reduced respiratory complications and shorter anesthesia-related times—support its use as an alternative airway device for this procedure for medical as well as for economic reasons.
- Open Access
- 22 May 2025
- Published by Elsevier in Best Practice & Research Clinical Anaesthesiology
- Vol. 39 (1) , 1-2
Perioperative care of the cancer patient
- 22 May 2025
- Published by Elsevier in Best Practice & Research Clinical Anaesthesiology
- Vol. 39 (1) , 1-2
Open AccessPerioperative care of the cancer patient
- 27 December 2024
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
Potential influence of different peri-operative analgesic regimens on tumour biology and outcome after oncologic surgery
The management of peri-operative pain is one of the pillars of anaesthesia and is of particular importance in patients undergoing surgery for solid malignant tumours. Amongst several options, the most commonly employed analgesic regimens involve opioids, NSAIDs and regional anaesthesia techniques with different local anaesthetics. In recent years, several research reports have tried to establish a connection between peri-operative anaesthesia care and outcome after cancer surgery. Experimental studies have indicated that certain pain management substances may influence cancer progression, mainly by modifying the tumour's response to surgical stress and peri-operative inflammation. However, these promising in-vitro and in-vivo data have yet to be confirmed by randomised clinical trials. The reason for this might lie with the nature of tumour biology itself, and in the diversity of patient and tumour phenotypes. In a translational approach, future research should therefore concentrate on patient and tumour-related factors or biomarkers, which might either influence the tumour and its microenvironment or predict potential responses to interventions, including the choice of the analgesic. This might not only be relevant for the daily practice of clinical anaesthesia, but would also be of great importance for patients undergoing cancer surgery, who might be able to receive an individualised anaesthetic regimen based on their phenotypic profile.
- 27 December 2024
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
Potential influence of different peri-operative analgesic regimens on tumour biology and outcome after oncologic surgery
The management of peri-operative pain is one of the pillars of anaesthesia and is of particular importance in patients undergoing surgery for solid malignant tumours. Amongst several options, the most commonly employed analgesic regimens involve opioids, NSAIDs and regional anaesthesia techniques with different local anaesthetics. In recent years, several research reports have tried to establish a connection between peri-operative anaesthesia care and outcome after cancer surgery. Experimental studies have indicated that certain pain management substances may influence cancer progression, mainly by modifying the tumour's response to surgical stress and peri-operative inflammation. However, these promising in-vitro and in-vivo data have yet to be confirmed by randomised clinical trials. The reason for this might lie with the nature of tumour biology itself, and in the diversity of patient and tumour phenotypes. In a translational approach, future research should therefore concentrate on patient and tumour-related factors or biomarkers, which might either influence the tumour and its microenvironment or predict potential responses to interventions, including the choice of the analgesic. This might not only be relevant for the daily practice of clinical anaesthesia, but would also be of great importance for patients undergoing cancer surgery, who might be able to receive an individualised anaesthetic regimen based on their phenotypic profile.
- Open Access
- 24 October 2024
- Published by Elsevier in Transplantation Proceedings
- Vol. 56 (9) , 2046-2053
Remote Kidney and Liver Injury After Transplantation of Lung Allografts in an Allogeneic Mouse Model
- 24 October 2024
- Published by Elsevier in Transplantation Proceedings
- Vol. 56 (9) , 2046-2053
Open AccessRemote Kidney and Liver Injury After Transplantation of Lung Allografts in an Allogeneic Mouse Model
- 12 October 2024
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 39 (2) , 469-479
Susceptibility of two different PCA pumps to inaccurate delivery associated with pole position at low flow-rates in a pediatric setting – an experimental study
Purpose Vertical displacement of infusion pumps used in patient-controlled analgesia can cause irregularities in drug delivery and is especially crucial at low flow rates, which are commonly used in pediatrics. There is only scarce data available regarding the extent of these inaccuracies. The current in vitro study therefore aimed at a comparison of the performance of two commonly used PCA pumps at different pole positions due to vertical displacement. Methods The Syramed® µSP6000 Chroma syringe infusion pump featuring a stepper motor drive was compared to the CADD®-Solis pump utilizing a linear peristaltic pump system at two different flow rates (0.3 ml/h and 1 ml/h) and three different levels of height (0, + 50 and − 50 cm). Flow patterns and delivered volumes were measured after every change in position and infusion boluses, retrograde aspiration volumes and zero-drug delivery time were calculated. Results The Syramed® pump was more susceptible to vertical displacement than the CADD®-Solis pump and showed overall greater inaccuracies in the delivered volumes as well as higher infusion boluses, retrograde aspiration volumes and zero-drug delivery time at both flow rates. Conclusion The observed differences between the pumps might be explained by the higher compliance of this syringe pump and the diverse working mechanisms. Overall, the CADD®-Solis pump might be considered a preferable option for patient-controlled analgesia in children. It is nonetheless essential for medical staff to be aware of the effects of vertical displacement of PCA pumps and to minimize these displacements as much as possible.
- 12 October 2024
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 39 (2) , 469-479
Susceptibility of two different PCA pumps to inaccurate delivery associated with pole position at low flow-rates in a pediatric setting – an experimental study
Purpose Vertical displacement of infusion pumps used in patient-controlled analgesia can cause irregularities in drug delivery and is especially crucial at low flow rates, which are commonly used in pediatrics. There is only scarce data available regarding the extent of these inaccuracies. The current in vitro study therefore aimed at a comparison of the performance of two commonly used PCA pumps at different pole positions due to vertical displacement. Methods The Syramed® µSP6000 Chroma syringe infusion pump featuring a stepper motor drive was compared to the CADD®-Solis pump utilizing a linear peristaltic pump system at two different flow rates (0.3 ml/h and 1 ml/h) and three different levels of height (0, + 50 and − 50 cm). Flow patterns and delivered volumes were measured after every change in position and infusion boluses, retrograde aspiration volumes and zero-drug delivery time were calculated. Results The Syramed® pump was more susceptible to vertical displacement than the CADD®-Solis pump and showed overall greater inaccuracies in the delivered volumes as well as higher infusion boluses, retrograde aspiration volumes and zero-drug delivery time at both flow rates. Conclusion The observed differences between the pumps might be explained by the higher compliance of this syringe pump and the diverse working mechanisms. Overall, the CADD®-Solis pump might be considered a preferable option for patient-controlled analgesia in children. It is nonetheless essential for medical staff to be aware of the effects of vertical displacement of PCA pumps and to minimize these displacements as much as possible.
- Top Cited PapersOpen Access
Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
Surgical excision of the primary tumor represents the most frequent and curative procedure for solid malignancies. Compelling evidence suggests that, despite its beneficial effects, surgery may impair immunosurveillance by triggering an immunosuppressive inflammatory stress response and favor recurrence by stimulating minimal residual disease. In addition, many factors interfere with the immune effectors before and after cancer procedures, such as malnutrition, anemia, or subsequent transfusion. Thus, the perioperative period plays a key role in determining oncological outcomes and represents a short phase to circumvent anesthetic and surgical deleterious factors by supporting the immune system through the use of synergistic pharmacological and non-pharmacological approaches. In line with this, accumulating studies indicate that anesthetic agents could drive both protumor or antitumor signaling pathways during or after cancer surgery. While preclinical investigations focusing on anesthetics’ impact on the behavior of cancer cells are quite convincing, limited clinical trials studying the consequences on survival and recurrences remain inconclusive. Herein, we highlight the main factors occurring during the perioperative period of cancer surgery and their potential impact on immunomodulation and cancer progression. We also discuss patient management prior to and during surgery, taking into consideration the latest advances in the literature.
Top Cited PapersOpen AccessPerioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
Surgical excision of the primary tumor represents the most frequent and curative procedure for solid malignancies. Compelling evidence suggests that, despite its beneficial effects, surgery may impair immunosurveillance by triggering an immunosuppressive inflammatory stress response and favor recurrence by stimulating minimal residual disease. In addition, many factors interfere with the immune effectors before and after cancer procedures, such as malnutrition, anemia, or subsequent transfusion. Thus, the perioperative period plays a key role in determining oncological outcomes and represents a short phase to circumvent anesthetic and surgical deleterious factors by supporting the immune system through the use of synergistic pharmacological and non-pharmacological approaches. In line with this, accumulating studies indicate that anesthetic agents could drive both protumor or antitumor signaling pathways during or after cancer surgery. While preclinical investigations focusing on anesthetics’ impact on the behavior of cancer cells are quite convincing, limited clinical trials studying the consequences on survival and recurrences remain inconclusive. Herein, we highlight the main factors occurring during the perioperative period of cancer surgery and their potential impact on immunomodulation and cancer progression. We also discuss patient management prior to and during surgery, taking into consideration the latest advances in the literature.
- Open Access
Association between Intraoperative Blood Transfusion, Regional Anesthesia and Outcome after Pediatric Tumor Surgery for Nephroblastoma
Background: Recent data suggest that anesthesiologic interventions—e.g., the choice of the anesthetic regimen or the administration of blood products—might play a major role in determining outcome after tumor surgery. In contrast to adult patients, only limited data are available regarding the potential association of anesthesia and outcome in pediatric cancer patients. Methods: A retrospective multicenter study assessing data from pediatric patients (0–18 years of age) undergoing surgery for nephroblastoma between 2004 and 2018 was conducted at three academic centers in Europe. Overall and recurrence-free survival were the primary outcomes of the study and were evaluated for a potential impact of intraoperative administration of erythrocyte concentrates, the use of regional anesthesia and the choice of the anesthetic regimen. The length of stay on the intensive care unit, the time to hospital discharge after surgery and blood neutrophil-to-lymphocyte ratio were defined as secondary outcomes. Results: In total, data from 65 patients were analyzed. Intraoperative administration of erythrocyte concentrates was associated with a reduction in recurrence-free survival (hazard ratio (HR) 7.59, 95% confidence interval (CI) 1.36–42.2, p = 0.004), whereas overall survival (HR 5.37, 95% CI 0.42–68.4, p = 0.124) was not affected. The use of regional anesthesia and the choice of anesthetic used for maintenance of anesthesia did not demonstrate an effect on the primary outcomes. It was, however, associated with fewer ICU transfers, a shortened time to discharge and a decreased postoperative neutrophil-to-lymphocyte ratio. Conclusions: The current study provides the first evidence for a possible association between blood transfusion as well as anesthesiologic interventions and outcome after pediatric cancer surgery.
Open AccessAssociation between Intraoperative Blood Transfusion, Regional Anesthesia and Outcome after Pediatric Tumor Surgery for Nephroblastoma
Background: Recent data suggest that anesthesiologic interventions—e.g., the choice of the anesthetic regimen or the administration of blood products—might play a major role in determining outcome after tumor surgery. In contrast to adult patients, only limited data are available regarding the potential association of anesthesia and outcome in pediatric cancer patients. Methods: A retrospective multicenter study assessing data from pediatric patients (0–18 years of age) undergoing surgery for nephroblastoma between 2004 and 2018 was conducted at three academic centers in Europe. Overall and recurrence-free survival were the primary outcomes of the study and were evaluated for a potential impact of intraoperative administration of erythrocyte concentrates, the use of regional anesthesia and the choice of the anesthetic regimen. The length of stay on the intensive care unit, the time to hospital discharge after surgery and blood neutrophil-to-lymphocyte ratio were defined as secondary outcomes. Results: In total, data from 65 patients were analyzed. Intraoperative administration of erythrocyte concentrates was associated with a reduction in recurrence-free survival (hazard ratio (HR) 7.59, 95% confidence interval (CI) 1.36–42.2, p = 0.004), whereas overall survival (HR 5.37, 95% CI 0.42–68.4, p = 0.124) was not affected. The use of regional anesthesia and the choice of anesthetic used for maintenance of anesthesia did not demonstrate an effect on the primary outcomes. It was, however, associated with fewer ICU transfers, a shortened time to discharge and a decreased postoperative neutrophil-to-lymphocyte ratio. Conclusions: The current study provides the first evidence for a possible association between blood transfusion as well as anesthesiologic interventions and outcome after pediatric cancer surgery.